Intelligent biomarker panel development for neurometabolic disease
1Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Developmental Medicine and Child Neurology
|August 18, 2022
Summary
No abstract available in PubMed .


